Merial is a world-leading animal healthcare company with a global total market share of more than 13 percent.
An innovation-driven leader, Merial makes significant investments in research and development, with nine research and development centres around the world. Merial is committed to developing pharmaceuticals and vaccines with the highest level of quality, safety and efficacy through an extensive network of 15 manufacturing sites globally.
Merial provides a comprehensive range of products to enhance the health, well-being and performance of a wide range of animals. We play a pioneering role with governments around the globe to contain and manage various animal diseases, recognising that the prevention and treatment of animal diseases are in the interests of protecting the health of animals and of man.
Merial employs approximately 5000 people worldwide and operates in more than 150 countries. Its 2007 sales were nearly $2.5 billion.
Merial Limited is a joint venture between Merck & Co., Inc. and sanofi-aventis.
|
